openPR Logo
Press release

Osteoporosis Drugs Market 2018 with Prominent Vendors Eli Lilly and Company, Merck & Co., Novartis International AG, Amgen Inc., etc. MRFR Unleashing Market Insight by 2022

06-01-2018 09:04 AM CET | Health & Medicine

Press release from: Market Research Futture

Osteoporosis Drugs Market 2018 with Prominent Vendors Eli Lilly

Global Osteoporosis Drugs Market Information, by drug class (Bisphosphonates, Calcitonins, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone (PTH) and Others), by route of administration (oral, injectable and others) and by gender (male and female) - Forecast to 2022

Taking all the factors into consideration, we expect the global osteoporosis market which totaled ~ $10,855 million to reach 14,300 million by 2022, growing with a CAGR of 4.7%.

KEY PLAYERS FOR OSTEOPOROSIS DRUGS MARKET

Eli Lilly and Company, Merck & Co., Novartis International AG, Amgen Inc., F. Hoffmann La Roche Ltd., Pfizer Inc., Novo Nordisk, Teva Pharmaceutical Industries Ltd. and others.

Get PDF Sample of This Report @ https://www.marketresearchfuture.com/sample_request/2479 .

MARKET SCENARIO FOR OSTEOPOROSIS DRUGS MARKET

Osteoporosis is weakening of bones due to lower bone mass resulting in and micro-architectural deterioration of bone tissue and subsequent higher risk of a broken fracture. It generally occurs at an advanced age and women are more susceptible to it than males by about three to four folds. WHO estimates that around 1.66 million hip fractures occur each year worldwide due to osteoporosis. According to national osteoporosis foundation about 54 million Americans suffer from osteoporosis.

The disease also has a genetic bias in that it Caucasians are more affected than Asians. The disease prevalence is lowest in African population.

The market driving factors were identified to be rise in the geriatric population, increased screening, drug induced osteoporosis, alcoholism and smoking, increased awareness and focus towards female health, rising prevalence of diseases, conditions and medical procedures that may cause bone loss such as cancer, autoimmune disorders, thalassemia, hormonal disorders, modern lifestyle etc.

The market restraints are loss of patents of block busters, greater penetration of generics and fragmentation of market, poor efficacy and side effects of present therapies, non-life threatening nature and poor symptoms of osteoporosis etc.

SEGMENTS FOR OSTEOPOROSIS DRUGS MARKET

Global osteoporosis drugs market has been segmented on the basis of drug class which comprises bisphosphonates, calcitonins, selective estrogen receptor modulators (SERMS), parathyroid hormone (PTH) and others. On the basis of route of administration; market is segmented into oral, injectable and others. On the basis of gender the market is segmented into male and female.

REGIONAL ANALYSIS FOR OSTEOPOROSIS DRUGS MARKET

Globally America is the largest market for osteoporosis drugs. Europe is the second-largest market for osteoporosis drugs. The developed regions are expected to hold their market leadership in the near future but with falling market share due to rise of Asia Pacific region which is expected to be fastest growing region in osteoporosis drugs market. The Asia pacific region will be led by China and India. Africa is expected to be a laggard in the global osteoporosis market.

Get Discount on This Premium Report@ https://www.marketresearchfuture.com/check-discount/2479 .

MAJOR TOC FOR OSTEOPOROSIS DRUGS MARKET

CHAPTER 1. INTRODUCTION

1.1 Definition

1.2 Scope of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure

CHAPTER 2. RESEARCH METHODOLOGY

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

CHAPTER 3. MARKET DYNAMICS

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

CHAPTER 4. MARKET FACTOR ANALYSIS

4.1 Porter’s Five Forces Model

4.1.1 Bargaining Power of Suppliers

4.1.2 Bargaining Power of Customer

4.1.3 Intensity of Competitor’s

4.1.4 Threat of New Entrants

CHAPTER 5. GLOBAL OSTEOPOROSIS DRUGS MARKET, BY DRUG CLASS

5.1 Introduction

5.2 Bisphosphonates

5.3 Calcitonins

5.4 Selective Estrogen Receptor Modulators (SERMs)

5.5 Parathyroid Hormone (PTH)

5.6 Others

TOC CONTINUED…

Ask to Expert Inquire @ https://www.marketresearchfuture.com/enquiry/2479 .

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future, Office No. 528,
Amanora Chambers Magarpatta Road,
Hadapsar, Pune - 411028 Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Osteoporosis Drugs Market 2018 with Prominent Vendors Eli Lilly and Company, Merck & Co., Novartis International AG, Amgen Inc., etc. MRFR Unleashing Market Insight by 2022 here

News-ID: 1068041 • Views:

More Releases from Market Research Futture

Electrical & Electronics Testing, Inspection, & Certification Market worth USD 157.63 Billion, growing at a 5.17% CAGR by 2030
Electrical & Electronics Testing, Inspection, & Certification Market worth USD 1 …
Market Overview Market Research Future (MRFR) forecasts the Global Electrical & Electronics Testing, Examination, & Licensing Market will reach USD 157.63 billion by 2030, growing at a 5.17 % CAGR (forecast period). Compliance testing, accounting, inspection, quality control, and certificate are all part of the Electrical & Electronic Testing, Inspection, and Certification (TIC) services. These solutions are used by organizations across several industrial sectors to increase the efficiency and productivity of production
Cyber Security Market is Anticipated to Grow USD 390.2 Billion at a CAGR of 14.50% by 2030
Cyber Security Market is Anticipated to Grow USD 390.2 Billion at a CAGR of 14.5 …
Market overview According to the studies, the cyber security market will grow up to 390.2 billion USD by the end of the year 2025. The market will grow at a CAGR rate of 14.50% in the upcoming years. The global cyber security market was valued at around 155.23 billion USD in 2019. The market will grow up to 251.23 billion USD by the end of the year 2027. Even another report
Construction Repaint Market Research Report- Opportunities & Challenges With Totally Different Segments, Forecast- 2030
Construction Repaint Market Research Report- Opportunities & Challenges With Tot …
Market Overview Global Construction Repaint Industry is slated to surpass market size of USD 90 billion by the end of forecast period with CAGR of approximately 6%. Market Dynamics Construction repaint refers to paints that are used for maintenance, repairs, and restoration in residential, industrial, and institutional settings. Furthermore, increasing demand for housing development and high disposable income are some of the factors driving the construction repaint market. Furthermore, rising housing demand and
Solar Hybrid Inverter Market 2022 Analysis, Research, Review, Applications & Forecast to 2030
Solar Hybrid Inverter Market 2022 Analysis, Research, Review, Applications & For …
Overview: The global report on the solar hybrid inverter market includes a study that predicts valuation and CAGR. According to that, the market valuation could cross USD 13.46 Billion by 2027, with a CAGR of 8.90% during the forecast period of 2020 to 2027. Market Research Future (MRFR) predicts that the market would benefit from factors like the rising concerns for eco-friendly measures, investments in research and development projects, favorable government

All 5 Releases


More Releases for DRUG

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug